A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT

Clinical trial NCT06805474 · RECRUITING

Trial details

NCT number: NCT06805474
Sponsor: Nanoscope Therapeutics Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Macular Degeneration Geographic Atrophy Stargardt Disease

Start date: 2025-01-28
Primary completion: 2025-05-20
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.